SURVYR

ACH

Accendra Health, Inc.
$0.23
+$0.03 (16.50%)Oct 28 close
Healthcare CompareTechnicals
1M3M6M1Y2Y
-96%-69%-41%-13%+15%Oct 2025Oct 2026Apr 202652w high $5.6052w low $0.20
ACHSPY
Wall St. Highest PT $1.75 (+651.1%) Wall St. Avg PT $1.26 (+441.8%)
$0$2$3$4$5POC $3Hi $2Avg $1
Underwater Drawdown %Max DD -96.4%Current -95.7%
0.0%-96.4%
Relative Strength vs SPY-109.7% vs SPYUnderperforming
+126%0%-126%
1W
−$0.03 (10.38%)
1M
−$0.42 (64.15%)
3M
−$3.09 (92.98%)
6M
−$3.26 (93.32%)
YTD
−$2.57 (91.68%)
1Y
−$5.05 (95.59%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Hold
4 analysts · mean score 3.40
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$0.23
Average target$1.26
+$1.03 (+441.8%) upsideaverage target vs current price
CurrentAverageMedian
Low$0.50
Median$1.26
High$1.75
12-month Wall Street target range
Recent analyst rating changes · 8
Reiterated
2026-08-13 · UBS reiterated Neutral on ACH
Downgrade
2026-08-11 · Citigroup downgraded ACH from Buy to Neutral
Reiterated
2026-07-24 · Citigroup reiterated Buy on ACH
Reiterated
2026-05-12 · UBS reiterated Neutral on ACH
Reiterated
2026-05-12 · Citigroup reiterated Buy on ACH
Reiterated
2026-05-12 · Baird reiterated Outperform on ACH
All analyst rating changes ›

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$19.6M
P/E (next 12 months, estimated)3.0
52-week range$0.20 – $5.60
Revenue growth (latest quarter vs a year ago)-10.1%
Dividend yieldNo dividend
Analyst consensusHold (4)
Average analyst price target$1.26 (+442%)

What they do

Accendra Health, Inc. operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services.

Healthcare · Medical Distribution
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

No sector grades for ACH yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
Outside this model's universe or screens
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

ACH earningsReports tomorrow
Next report
Thu Oct 29, 2026Before the open
EPS consensus-$0.09 range -$0.42–$0.03
Revenue consensus$617.4M 5 analysts
Last 4 quarters · EPS vs estimate
Aug 10, 2026-$0.19est -$0.09−116.0%Below estimates
May 11, 2026-$0.04est -$0.10+59.3%Above estimates
Feb 19, 2026$0.21est $0.22−5.1%Below estimates
Oct 30, 2025$0.25est $0.23+6.4%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · refreshed 2026-10-21 01:32:52 ET
24-1125-0225-0525-0825-1026-0226-0526-08-0.190.55
EstimateActual (beat)Actual (miss)

Quarterly revenue

QuarterRevenueYoY
2026-06-30$613.2M-10.1%
2026-03-31$627.8M–
2025-12-31$709.0M–
2025-09-30$697.3M–
2025-06-30$681.9M–

Recent dividends

2021-12-14: $0.003 · 2021-09-14: $0.003 · 2021-06-14: $0.003 · 2021-03-12: $0.003 · 2020-12-14: $0.003 · 2020-09-14: $0.003 · 2020-06-12: $0.003 · 2020-03-13: $0.003

News & catalysts

More news
Same Day ACH Growth Propels the ACH Network Forward in Third Quarter of 2026
Business Wire · Oct 20
Disbo Expands Filevine Settlement Disbursements With Check and ACH Payment Options
GlobeNewswire · Oct 14
MassPay Adds Paymode Virtual Card and Premium ACH to Its Platform
PR Newswire · Oct 13
Accendra Health Receives NYSE Listing Notice
MT Newswires · Oct 09
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing Standard
Business Wire · Oct 09
Rating changes
Reiterated
2026-08-13 · UBS reiterated Neutral on ACH
Downgrade
2026-08-11 · Citigroup downgraded ACH from Buy to Neutral
Reiterated
2026-07-24 · Citigroup reiterated Buy on ACH
Reiterated
2026-05-12 · UBS reiterated Neutral on ACH
Reiterated
2026-05-12 · Citigroup reiterated Buy on ACH
Reiterated
2026-05-12 · Baird reiterated Outperform on ACH

Third-party analyst actions, not SURVYR.'s views. All rating changes

Insider trades
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-21 01:32:52 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026